SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is experiencing heightened volatility as investors debate the impact of AI-driven cybersecurity demand versus concerns over high valuations and competitive pressure. The stock remains a focal point for the community due to analyst price target adjustments, ongoing institutional rotation, and the broader debate over whether platform consolidation will sustainably offset high acquisition costs.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant market attention following a massive stock offering that was heavily oversubscribed, signaling strong institutional appetite for the semiconductor giant. Investors are closely tracking bullish signals, including a substantial personal investment by the CEO and aggressive call option activity, as the community debates the stock's potential for a long-term turnaround in the competitive foundry and AI infrastructure space.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Investors are actively debating whether the semiconductor sector is experiencing a genuine recovery or a temporary relief rally following aggressive liquidations, with sentiment heavily influenced by rotation into software names and volatility in memory stocks like Micron. The community is sharply divided between those calling for a broader structural bubble pop and those urging patience, focusing heavily on how AI infrastructure spending and Treasury yields will dictate the next trend for the SOXX ETF.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The XRP community is actively debating the coin's utility and long-term potential as institutional focus shifts toward regulatory clarity, particularly surrounding potential legislation. Discussion remains polarized between those accumulating at current price levels and others concerned about network dilution and the influence of broader crypto market volatility.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is gaining significant market attention as a new $37.50 per share acquisition offer from an Israeli-led consortium challenges the previously agreed-upon $35 takeover deal with Hapag-Lloyd. Investors are actively discussing the potential for a bidding war, the strategic implications of keeping the company under Israeli control, and the ongoing expectation of robust dividends despite the merger uncertainty.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Investors are closely monitoring Bitcoin's recent price consolidation and the broader crypto market's reaction to uncertainty surrounding the CLARITY Act and institutional capital flows. Community discussion remains heavily polarized between those viewing current volatility as a strategic buying opportunity and others expressing concern over potential further downside risks tied to macroeconomic indicators.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is trending as investors digest a strong earnings report featuring revenue growth and a return to profitability, while community sentiment remains highly bullish on the company's long-term warehouse automation and AI-driven robotics backlog. Discussions are dominated by debates over the stock's valuation relative to execution speed, as traders weigh the impact of heavy institutional interest against ongoing concerns regarding customer concentration and insider selling.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is trending as investors digest the company's recent earnings performance, with many in the community highlighting its strong fundamentals and growth potential compared to fintech competitors. While some are concerned about potential short-term volatility and valuation, others are focused on institutional accumulation and the anticipation of a potential short squeeze.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as market participants weigh persistent concerns over rising global bond yields and geopolitical tensions in the Middle East against ongoing AI infrastructure capital expenditure. Community sentiment remains deeply divided, with traders closely monitoring key support levels and dealer gamma positioning while debating whether the current pullback represents a healthy consolidation or a systemic credit risk.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is currently under pressure as the stock touches new lows, driven by a recent global recall concerning radio software defects and persistent investor concern over high dealer inventories and sluggish North American product demand. Despite these headwinds, bullish community members are aggressively accumulating shares, pointing to strong cash reserves and a favorable valuation relative to the company's long-term turnaround plan and upcoming vehicle rollouts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge

BBIO's Q2 loss misses estimates, but revenues beat expectations as Attruby sales more than tripled, fueling growth and pipeline advances.

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Vertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face major 2026 catalysts, from FDA decisions to late-stage readouts.

BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -21.88% and +9.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Viatris Gears Up to Report Q2 Earnings: What's in the Cards?

VTRS readies Q2 results as growth in key markets and brands may offset manufacturing and pricing headwinds across parts of its portfolio.

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?

BridgeBio Pharma (BBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FDA Accepts BridgeBio's Filing for Rare Genetic Disease Drug

BBIO's FDA filing for encaleret in ADH1 has been accepted, moving the rare disease candidate closer to a decision expected by May 2027.

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo

BioMarin's FDA filing for full Voxzogo approval in achondroplasia has been accepted, with a regulatory decision expected by Feb. 28, 2027.

How a Rival's Clinical Setback Sent BBIO Stock to a 52-Week High

BridgeBio Pharma hit a 52-week high after a rival's phase III setback boosts confidence in Attruby's competitive position in ATTR-CM.

BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last?

BridgeBio Pharma (BBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

BBIO Stock Surges 16% As AstraZeneca-Ionis Heart Drug Trial Misses Goal — BofA Calls Failure ‘A Big Surprise’

Equity

AstraZeneca and Ionis announced on Thursday  that their late-stage CARDIO-TTRansform trial for eplontersen (Wainua) failed to meet its main goal.


BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$82.98
Prev Close	$79.89
Open	$80.54
Dividend Yield	0.00%
50-Day Moving Average	$77.75
Beta	1.23
Avg. Volume	3.34M
PE Ratio	-23.25

52-Week High	$93.42
52-Week Low	$46.81
Market Capitalization	$15.62B
EPS (Annual)	-$3.79
Price to Book	-6.44
Revenue Per Employee	$598,421.93

Feed

News

Sentiment

Earnings

Fundamentals

Info